Baker DG, Nievergelt CM, OConnor DT
AS GLP-1s ORIGINALLY INTENDED TO TREAT TYPE 2 DIABETES (T2D) AND OFTEN DELIVERED WITH INJECTION PENS DEVELOPED FOR INSULIN ARE INCREASINGLY USED TO TREAT OBESITY, PERHAPS IT IS WORTH RETHINKING THE BASIS OF THESE DESIGNS TO ACCOMMODATE A USER GROUP THAT MAY HAVE DIFFERENT REQUIREMENTS. People with diabetes depend on these devices for survival, and the devices have been optimised accordingly for their ease of use, safety and reliability
Foggy focus
The Business Case for Employer-Based GLP-1 Coverage Mike Hollan , Susan Thomas Chief commercial officer Susan Thomas from LucyRx explains why coverage isnt a one-size-fits all problem
Sultan Qaboos Univ Med J 15:e440e441 Savoia F, Ricci L, Patrizi A, Gaddoni G (2015) Congenital melanotic macules of the tongue
Enhances Skin Radiance : Regular collagen supplementation encourages natural skin renewal and a healthier skin barrier